Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy.

  title={Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy.},
  author={Lili Kazemi-Shirazi and Verena Niederberger and Birgit Linhart and Jonas {\AA}. Lidholm and Dietrich Kraft and Rudolf Valenta},
  journal={International archives of allergy and immunology},
  volume={127 4},
During the past decade an increasing number of recombinant allergens have become available, representing a significant proportion of the epitope complexity of natural allergen extracts. Component-resolved diagnosis with recombinant allergens reveals the antibody reactivity profile of allergic patients and identifies the disease-eliciting allergen molecules. This article exemplifies how recombinant allergen molecules with high cross-reactive potential can be used as marker allergens to identify… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 48 extracted citations

Domestic mite–induced allergy: Causes, diagnosis, and future prospects

International journal of immunopathology and pharmacology • 2018

Single recombinant and purified major allergens and peptides: How they are made and how they change allergy diagnosis and treatment.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2017

Allergen extract vs. component sensitization and airway inflammation, responsiveness and new-onset respiratory disease.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology • 2016

Similar Papers

Loading similar papers…